The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

We just covered the Claude Stock Portfolio: Top 10 Stocks to Buy According to AI Chatbot. Ardelyx Inc. (NASDAQ:ARDX) ranks #9 (see Claude Stock Portfolio: Top 5 Stocks to Buy According to AI Chatbot).

Number of Hedge Funds: 30

Biotech company Ardelyx Inc. (NASDAQ:ARDX) is one of the recent additions in the Claude portfolio.

Anthropic’s AI chatbot Claude said it likes Ardelyx Inc. (NASDAQ:ARDX) because its IBSRELA drug is the only approved NHE3 inhibitor for IBS-C, a condition involving chronic constipation. Claude said the drug works differently from competing treatments, potentially making it an option for patients who cannot tolerate those therapies.

The AI chatbot also highlighted Ardelyx Inc’s (NASDAQ:ARDX) strong growth, noting that first-quarter 2026 revenue rose 58% year over year to $70.1 million, while the company maintained its full-year guidance range of $410 million to $430 million.

Claude believes Ardelyx Inc. (NASDAQ:ARDX) could be a takeover target in the future.

While we acknowledge the potential of ARDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey on Google News.